Sedia Biosciences

Sedia Biosciences

Biotechnology, Beaverton, Oregon, United States, 11-50 Employees

sediabio.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +15*********

Who is SEDIA BIOSCIENCES

Sedia Biosciences is a privately held medical device and diagnostics company founded in 2009 and based in Portland Oregon. Our commitment is to become a leader in three areas intended to ...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 8071 | NAICS Code: 621999 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SEDIA BIOSCIENCES

Sedia Biosciences Org Chart and Mapping

VP-Level
Employees

Jason Reynolds

Director of Program Management

Joshua Owens

Vice President, Sales, Marketing and Supply Chain

Robbie Johnson

Quality Control Assistant Scientist

Midorie Padin

Quality Assurance Associate

Matt Quinn

Senior Project Manager

Paul Smith

Director, Product/Technical Support

Victoria Chin

Quality Control Assistant Scientist

Alan Lofquist

VP, Research and Development - In Vitro Diagnostics

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Sedia Biosciences

Answer: Sedia Biosciences's headquarters are located at Beaverton, Oregon, United States

Answer: Sedia Biosciences's phone number is +15*********

Answer: Sedia Biosciences's official website is https://sediabio.com

Answer: Sedia Biosciences's revenue is $10 Million to $25 Million

Answer: Sedia Biosciences's SIC: 8071

Answer: Sedia Biosciences's NAICS: 621999

Answer: Sedia Biosciences has 11-50 employees

Answer: Sedia Biosciences is in Biotechnology

Answer: Sedia Biosciences contact info: Phone number: +15********* Website: https://sediabio.com

Answer: Sedia Biosciences is a privately held medical device and diagnostics company founded in 2009 and based in Portland Oregon. Our commitment is to become a leader in three areas intended to advance global access to care as reflected by our: (1) expertise in rapid point of care diagnostic assays, especially alternative fluid (e.g. oral, urine, etc) assays, (2) scientific and market leadership in novel HIV epidemiological disease incidence assays and other public health tools and (3) novel clinical specimen collection devices to improve and facilitate remote collection of specimens for follow-up testing. Sedia brings together a dedicated team of researchers, scientists and business people that share our common mission and develops, manufactures and licenses these technology and products to improve access to medical care around the world.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access